Don't ignore those symptoms. Head and neck cancers are far more manageable, and often curable, with less aggressive treatment ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Head and neck cancers — including oral, throat, voice box (larynx), nasal cavity, sinuses, salivary glands, and thyroid cancers — represent a diverse group of diseases that are significantly ...

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival ...

An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...